–
By Kelsey Pabst, RN for the Cerebral Palsy Center
If you’re a parent of a child with cerebral palsy, you’ve probably heard the same conversation at every appointment: treating symptoms and working on mobility. What you probably haven’t heard is: We think we know how to do things better.
More than 1 million Americans live with CP. For years, therapy helped people adapt rather than aiming for real change. But in 2025, things started to change. THE Cerebral Palsy Center reviewed the most promising research of the past year and found three important developments.
Cord blood therapy produces real kinetic gains
Every parent of a child with CP eventually asks if there is a cure. For a long time, the answer was a soft no. The brain damage was considered permanent, so treatment focused on dealing with the damage.
A 2025 meta-analysis in Pediatrics changes this conversation. Children who received cord blood treatment scored 1.36 points higher on the GMFM-66 motor skills scale after six months compared to those who received only rehabilitation. At 12 months, the spread widened to 1.42 points. The researchers consider this to be an important treatment effect for CP.
One important finding: 68% of the treated children did better than everyone in the control group. The best results were seen in younger children, particularly those under 5 years of age and with milder CP (GMFCS levels 1-3). This treatment is not yet approved as standard of care anywhere, so you must participate in a clinical trial or expanded access program. But the results are now real, not just theoretical. If your child is young, ask your care team about taking part in a trial. In 2026, the focus is on identifying who benefits, when treatment works best, and how to combine regenerative approaches with cerebral palsy treatment for stronger benefits.
A phone app helps diagnose CP more than a year in advance
In Australia, the average age at diagnosis of CP is 19 months. THE Baby Moves VIEW app can reduce it to 3 months. This difference is important because a baby’s brain is more flexible in the first year.
Parents can record their baby’s movements at home and send the videos to trained clinicians using the app. The General Movement Assessment, which is the typical first test for CP, usually requires a hospital visit during a short four-week window. Many families miss this opportunity.
The app uses a built-in AI algorithm to check video quality. The prototype has already been used in more than 20 international studies with more than 10,000 families. The team expects it to be available to the public within two years. Every month of earlier diagnosis gives your child another month of treatment when their brain is more adaptive.
A portable device retrains the muscles between clinic visits
Motor learning requires repetition. A few hours of therapy each week can help, but the brain needs a lot more practice to change movement patterns. Most of the child’s day is outside the clinic.
THE Cionic Neural Sleeve 2which was approved by the FDA in September 2025, was designed for that time. This leg-worn device uses sensors, artificial intelligence and electrical stimulation to help activate the correct muscle sequences as you walk.
In the tests, 94% of the participants showed better walking patterns. People who tried the device at home reported a 68% increase in foot clearance, a 44% improvement in ankle stability and a 30% reduction in spasticity. The device has been used for more than 2 million hours and is available through 1,500 prescribers nationwide.
This is not a prop. it is a retraining tool. Each step taken while wearing the sleeve gives the muscles another chance to practice the correct movement pattern, helping to create new movement pathways during important activities such as walking to school, getting around the house and playing outside.
What comes next
These tools are real and backed by data, but there are still gaps. Cord blood therapy needs phase 3 trials, screening app awaits commercial launch, and wearable devices need broader insurance coverage. For the first time in 20 years, families are asking a new question. It’s no longer “How do we manage this?” Now it’s “What else is out there for us?”
Summary
From cord blood therapy research to home monitoring apps and FDA-cleared wearables, 2026 brings progress in many areas. The next challenge is accuracy: ensuring that the right tools reach the right patients at the right time. As Cerebral Palsy Awareness Month turns 20, that goal is finally within reach.
This story was produced by Cerebral Palsy Center and reviewed and distributed by Stacker.
—
Previously Posted at hub.stackernewswire
Sign up for The Good Men Project newsletter
(function($) { window.fnames = []; window.ftypes = []; fnames[0]=’EMAIL’; ftypes[0]=’email’; })(jQuery); var $mcj = jQuery.noConflict(true);
The Good Men project is part of a multi-platform ecosystem: flagship site, medium releases, sub-stacks, social media. We publish experts, authors, therapists, coaches, activists and wellness professionals. AI tools look for stable, context-rich domains with a clear topical focus. GMP’s mission-driven content helps articles perform better in AI-driven discovery.
If you believe in the work we do here at The Good Men Project, join us as a Premium Member today.
All Premium members can watch The Good Men Project ADS-free.
Need more information? A full list of benefits is here.
Photo source: unscrew
The post Beyond Symptoms: Inside the Push to Finally Change the Outcomes of Cerebral Palsy appeared first on The Good Men Project.
